{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T02:53:53Z","timestamp":1740106433709,"version":"3.37.3"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100006814","name":"FMC Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006814","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology and Applied Pharmacology"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.taap.2024.116959","type":"journal-article","created":{"date-parts":[[2024,5,9]],"date-time":"2024-05-09T16:01:29Z","timestamp":1715270489000},"page":"116959","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Effects of pethoxamid treatment on the disposition of thyroxine in rats"],"prefix":"10.1016","volume":"487","author":[{"given":"Appavu","family":"Chandrasekaran","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karin","family":"Bentley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"McClanahan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gopinath","family":"Nallani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.taap.2024.116959_bb0005","article-title":"Peer review of the pesticide risk assessment of the active substance pethoxamid","volume":"15","author":"Arena","year":"2017","journal-title":"EFSA J."},{"key":"10.1016\/j.taap.2024.116959_bb0010","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1168663","article-title":"A minimal human physiologically based kinetic model of thyroid hormones and chemical disruption of plasma thyroid hormone binding proteins","volume":"14","author":"Bagga","year":"2023","journal-title":"Front. Endocrinol."},{"issue":"1","key":"10.1016\/j.taap.2024.116959_bb0015","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1006\/taap.1994.1174","article-title":"Reduction of thyroid hormone levels and alteration of thyroid function by four representative UDP-glucuronosyltransferase inducers in rats","volume":"128","author":"Barter","year":"1994","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"1","key":"10.1016\/j.taap.2024.116959_bb0020","doi-asserted-by":"crossref","DOI":"10.1177\/019262339702500109","article-title":"Mechanistic data and risk assessment of selected toxic end points of the thyroid gland","volume":"25","author":"Capen","year":"1997","journal-title":"Toxicol. Pathol."},{"issue":"1\u20133","key":"10.1016\/j.taap.2024.116959_bb0025","article-title":"The rat as model for the study of drug effects on thyroid function: consideration of methodological problems","volume":"5","author":"D\u00f6hler","year":"1979","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.taap.2024.116959_bb0030","series-title":"Critical Reviews in Toxicology","article-title":"Mode of action and human relevance analysis for nuclear receptor-mediated liver toxicity: A case study with phenobarbital as a model constitutive androstane receptor (CAR) activator","volume":"Vol. 44","author":"Elcombe","year":"2014"},{"key":"10.1016\/j.taap.2024.116959_bb0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.yrtph.2017.11.003","article-title":"Human relevance of rodent liver tumors: key insights from a toxicology forum workshop on nongenotoxic modes of action","volume":"92","author":"Felter","year":"2018","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.taap.2024.116959_bb0040","series-title":"Encyclopedia of Toxicology","article-title":"Common mechanisms of toxicity in pesticides","author":"Hern\u00e1ndez","year":"2024"},{"key":"10.1016\/j.taap.2024.116959_bb0045","series-title":"Current Opinion in Toxicology","article-title":"Mechanisms underlying disruptive effects of pesticides on the thyroid function","volume":"19","author":"Hern\u00e1ndez","year":"2020"},{"issue":"8","key":"10.1016\/j.taap.2024.116959_bb0050","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1289\/ehp.98106437","article-title":"Mode of carcinogenic action of pesticides inducing thyroid follicular cell tumors in rodents","volume":"106","author":"Hurley","year":"1998","journal-title":"Environ. Health Perspect."},{"issue":"8","key":"10.1016\/j.taap.2024.116959_bb0055","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1289\/ehp.98106437","article-title":"Mode of carcinogenic action of pesticides inducing thyroid follicular cell tumors in rodents","volume":"106","author":"Hurley","year":"1998","journal-title":"Environ. Health Perspect."},{"issue":"4","key":"10.1016\/j.taap.2024.116959_bb0060","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1124\/dmd.109.031153","article-title":"Polychlorinated biphenyl-mediated decrease in serum thyroxine level in rodents","volume":"38","author":"Kato","year":"2010","journal-title":"Drug Metab. Dispos."},{"issue":"3","key":"10.1016\/j.taap.2024.116959_bb0065","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.taap.2010.09.024","article-title":"A possible mechanism for the decrease in serum thyroxine level by phenobarbital in rodents","volume":"249","author":"Kato","year":"2010","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.taap.2024.116959_bb0070","series-title":"Xenobiotica","article-title":"Species differences in the hepatic effects of inducers of CYP2B and CYP4A subfamily forms: relationship to rodent liver tumour formation","volume":"Vol. 39","author":"Lake","year":"2009"},{"issue":"2","key":"10.1016\/j.taap.2024.116959_bb0075","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1093\/toxsci\/kfp026","article-title":"Hepatobiliary disposition of thyroid hormone in Mrp2-deficient TR\u2212 rats: reduced biliary excretion of thyroxine glucuronide does not prevent xenobiotic-induced hypothyroidism","volume":"108","author":"Lecureux","year":"2009","journal-title":"Toxicol. Sci."},{"author":"Liebl","key":"10.1016\/j.taap.2024.116959_bb0080"},{"key":"10.1016\/j.taap.2024.116959_bb0085","series-title":"Angewandte Chemie - International Edition","article-title":"Chemistry and biology in the biosynthesis and action of thyroid hormones","volume":"Vol. 55","author":"Mondal","year":"2016"},{"year":"2011","series-title":"Guide for the Care and Use of Laboratory Animals","key":"10.1016\/j.taap.2024.116959_bib126"},{"year":"2023","series-title":"Constitutive Androstane Receptor Activation Leading to Hepatocellular Adenomas and Carcinomas in the Mouse and the Rat","author":"Peffer","key":"10.1016\/j.taap.2024.116959_bb0090"},{"key":"10.1016\/j.taap.2024.116959_bb0095","article-title":"Species differences in phenobarbital-mediated UGT gene induction in rat and human liver microtissues","volume":"8","author":"Plummer","year":"2021","journal-title":"Toxicol. Rep."},{"issue":"2","key":"10.1016\/j.taap.2024.116959_bb0100","doi-asserted-by":"crossref","DOI":"10.1172\/JCI108301","article-title":"Metabolism of thyroxine binding globulin in man. Abnormal rate of synthesis in inherited thyroxine binding globulin deficiency and excess","volume":"57","author":"Refetoff","year":"1976","journal-title":"J. Clin. Invest."},{"issue":"5","key":"10.1016\/j.taap.2024.116959_bb0105","doi-asserted-by":"crossref","first-page":"391","DOI":"10.3109\/00498254.2013.847990","article-title":"In vitro metabolism of thyroxine by rat and human hepatocytes","volume":"44","author":"Richardson","year":"2014","journal-title":"Xenobiotica"},{"issue":"3","key":"10.1016\/j.taap.2024.116959_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.yrtph.2014.10.003","article-title":"Thyroid tumor formation in the male mouse induced by fluopyram is mediated by activation of hepatic CAR\/PXR nuclear receptors","volume":"70","author":"Rouqui\u00e9","year":"2014","journal-title":"Regul. Toxicol. Pharmacol."},{"author":"US EPA","key":"10.1016\/j.taap.2024.116959_bb0115"},{"key":"10.1016\/j.taap.2024.116959_bb0120","series-title":"Drug Metabolism and Disposition","article-title":"Mechanisms by which inducers of drug metabolizing enzymes Alter thyroid hormones in rats","volume":"Vol. 50","author":"Vansell","year":"2022"},{"issue":"3","key":"10.1016\/j.taap.2024.116959_bb0125","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1006\/taap.2001.9278","article-title":"Increased biliary excretion of thyroxine by microsomal enzyme inducers","volume":"176","author":"Vansell","year":"2001","journal-title":"Toxicol. Appl. Pharmacol."}],"container-title":["Toxicology and Applied Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X24001571?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X24001571?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T23:08:57Z","timestamp":1718233737000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041008X24001571"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":26,"alternative-id":["S0041008X24001571"],"URL":"https:\/\/doi.org\/10.1016\/j.taap.2024.116959","relation":{},"ISSN":["0041-008X"],"issn-type":[{"type":"print","value":"0041-008X"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of pethoxamid treatment on the disposition of thyroxine in rats","name":"articletitle","label":"Article Title"},{"value":"Toxicology and Applied Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.taap.2024.116959","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"116959"}}